Performance of the QuickVue Influenza A+B rapid test for pandemic H1N1 (2009) virus infection in adults

PLoS One. 2011;6(12):e28089. doi: 10.1371/journal.pone.0028089. Epub 2011 Dec 1.

Abstract

To investigate the diagnostic accuracy of the QuickVue® Influenza A+B rapid test we conducted a prospective observational study in which this rapid test was compared with a real-time reverse transcription polymerase chain reaction (RT-PCR) for pandemic influenza A H1N1 (2009) infection in Austrian adults. The sensitivity, specificity, and positive and negative predictive values of the QuickVue test compared with the RT-PCR were 26% (95% CI 18-35), 98% (95% CI 92-100), 94% (95% CI 80-99) and 50% (95% CI 42-58), respectively. The prevalence of pandemic H1N1 (2009) virus infection among the 209 patients included in the study was 57%. Our data suggest that a positive QuickVue test provides considerable information for the diagnosis of pandemic influenza A H1N1 (2009) virus infection in young adults but that a negative QuickVue test result should, if relevant for patient management or public health measures, be verified using PCR.

MeSH terms

  • Adolescent
  • Adult
  • DNA, Viral / genetics*
  • Female
  • Follow-Up Studies
  • Humans
  • Influenza A Virus, H1N1 Subtype / genetics
  • Influenza A Virus, H1N1 Subtype / isolation & purification*
  • Influenza, Human / diagnosis*
  • Influenza, Human / genetics
  • Influenza, Human / virology*
  • Male
  • Pandemics
  • Prognosis
  • Prospective Studies
  • Reagent Kits, Diagnostic*
  • Real-Time Polymerase Chain Reaction
  • Sensitivity and Specificity
  • Viral Load / genetics*
  • Young Adult

Substances

  • DNA, Viral
  • Reagent Kits, Diagnostic